SCHEMBL13009129

SCHEMBL13009129

c1ccc(-c2ccc(-c3c4ccc(N5c6ccccc6Cc6ccccc65)cc4c(-c4cccc5ccccc45)c4ccc(N5c6ccccc6Cc6ccccc65)cc34)c3ccccc23)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTDSP1 Q9GZU7 1/20 0.35
PDE6D O43924 1/20 0.34
HPGD P15428 3/20 0.33
CA12 O43570 2/20 0.33
CA1 P00915 2/20 0.33
CA2 P00918 2/20 0.33
CA9 Q16790 2/20 0.33
POLB P06746 1/20 0.33
TNF P01375 1/20 0.33
MCL1 Q07820 1/20 0.32
ACMSD Q8TDX5 1/20 0.32
EGFR P00533 1/20 0.32
ALK Q9UM73 1/20 0.32
KDM4E B2RXH2 2/20 0.31
ALDH1A1 P00352 2/20 0.31
MAPT P10636 2/20 0.31
MEN1 O00255 1/20 0.31
MPI P34949 1/20 0.31
KMT2A Q03164 1/20 0.31
SOS1 Q07889 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13008789 0.94 PDE6D (0.34) CTDSP1PDE6DHPGDPOLBKDM4E
SCHEMBL13009393 0.94 PDE6D (0.34) CTDSP1PDE6DHPGDPOLBKDM4E
SCHEMBL13427045 0.93 PDE6D (0.33) CTDSP1PDE6DHPGDCA12CA1
SCHEMBL13427030 0.93 CA12 (0.33) CTDSP1PDE6DHPGDCA12CA1
SCHEMBL13428191 0.93 PDE6D (0.34) CTDSP1PDE6DHPGDCA12CA1
SCHEMBL13009118 0.93 PDE6D (0.36) CTDSP1PDE6DHPGDCA12CA1
SCHEMBL13426910 0.93 POLB (0.38) CTDSP1HPGDPOLBKDM4EALDH1A1
SCHEMBL13008793 0.92 POLB (0.33) CTDSP1PDE6DHPGDCA12CA1
SCHEMBL13008620 0.92 PDE6D (0.38) CTDSP1PDE6DHPGDCA12CA1
SCHEMBL13008783 0.91 POLB (0.35) CTDSP1PDE6DHPGDCA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2256176-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same Gracel Display Inc. (KR) 2010-12-01 EP disclosed
US-20100051106-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-03-04 US disclosed
US-20100051106-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-03-04 US disclosed
EP-2141214-A2 Novel organic electroluminescent compounds and organic electroluminescent device using the same Gracel Display Inc. (KR) 2010-01-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100051106-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same RPL36, RPL39, RPL36A CTDSP1 2078/4885PDE6D 3559/4885HPGD 4470/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.